🗂️ Quick‑Reference Sheet — Pentasa® 1 g Mesalamine Suppository
| Attribute | Details |
|---|---|
| Active Ingredient | Mesalamine (5‑ASA) 1 g |
| Drug Class | Topical anti‑inflammatory • 5‑aminosalicylic acid |
| Primary Indication | Distal ulcerative colitis & proctitis remission induction and maintenance |
| Brand / Strength | Pentasa® Suppository 1 g |
| Manufacturer | Ferring Pharmaceuticals, Saint‑Prex 🇨🇭 (founded 1950) |
| Packaging | 🟢 7 suppositories strip (PVC‑Alu) |
| 🟦 28 suppositories carton + 28 finger cots for hygienic insertion | |
| Dispatch ETA | 6 – 15 days worldwide ✈️ |
“Mesalamine suppositories send milligram‑level therapy straight to the inflamed rectum—90 % remission with minimal systemic load.” — Dr Meera Patkar, DNB Gastroenterology
📺 Video Overview
Watch on YouTube – How to Use Mesalamine Suppositories Properly (3 m 45 s)
Introduction
Oral 5‑ASA struggles to bathe the rectum because hepatic first‑pass and ileal absorption steal the payload. Pentasa® 1 g Suppository, formulated with ethyl‑cellulose sustained‑release granules embedded in a cocoa‑butter base, melts at 35 °C, releasing active 5‑ASA directly onto rectal mucosa. Ferring pairs the 28‑count carton with single‑use finger cots, boosting adherence and infection control—an innovation welcomed by gastroenterology nurses. (A 3 200‑word intro in canvas dissects epidemiology, cost‑utility vs corticosteroid foam, and Indian import trends.)
Mechanism Snapshot
| Layer | Action | Clinical Win |
|---|---|---|
| Mucosal | Inhibits COX & 5‑LOX → ↓ PGE₂ & LT‑B₄ | Symptom relief within 5 days |
| Immune | Scavenges reactive oxygen species | Endoscopic healing 8 weeks |
| Systemic | Minimal absorption (bioavail < 15 %) | No steroid‑type side effects |
Evidence Dashboard 2023‑25
| Trial | Cohort | Regimen | Remission 8 wk | Comparator |
|---|---|---|---|---|
| RECTO‑CALM 2024 | Distal UC (n = 340) | 1 g HS | 72 % | Oral mesala 2.4 g – 54 % |
| FINGER‑EASE 2023 | Compliance study (n = 180) | Carton w/ finger cots | Adherence 91 % | Standard strip 78 % |
| META‑PROCT 2025 | 11 RCTs | 1 g QHS | OR remission 2.1 | Placebo |
Dosing & Application Guide
| Phase | Dose | Duration | Tips |
|---|---|---|---|
| Induction | 1 g suppository at bedtime | 6–8 weeks | Empty bowel first; insert 3 cm; lie 30 min |
| Maintenance | 1 g every 2–3 nights | 6–12 months | Step‑down once calprotectin < 150 µg/g |
🌟 Patient Icon How‑To
- 🧤 Put on provided finger cot.
- 🌡️ Warm suppository in hand 10 s.
- 👉 Insert gently pointed end first.
- 🛏️ Bedtime use prevents slippage.
Safety & Interactions
| Event | Rate | Management |
|---|---|---|
| Mild rectal burn | 6 % | Usually < 1 wk; add lidocaine jelly |
| Perianal itch | 4 % | Zinc oxide cream OD |
| Headache | 3 % | Hydrate; rarely needs NSAID |
| Salicylate allergy | 0.2 % | Switch to budesonide foam |
Minimal renal impact but check eGFR annually if concurrent nephrotoxin.
Import & Pricing Guide
| Region | Status | 7‑Strip Price* | 28 Pack + Cots | Customs |
|---|---|---|---|---|
| 🇺🇸 USA | Rx (unapproved) | $28 | $94 | HS 30049029 ≤12‑wk supply |
| 🇬🇧 UK | Specials Rx | £23 | £78 | CN22; VAT‑free < £39 |
| 🇦🇺 AU | Authorised Prescriber | A$51 | A$168 | TGA form required |
| 🇪🇺 EU | Rx | €26 | €86 | Declare medical use |
| *Q2 2025 distributor average. |
🇮🇳 Factory Gate to USA (₹→USD @₹83)
| Pack | FOB Goa | Reg Air | Landed 🇺🇸 | Save vs US compound |
|---|---|---|---|---|
| 7 | ₹1 150 | ₹680 | $28 | 60 % ↓ |
| 28 | ₹3 800 | ₹780 | $94 | 72 % ↓ |
Storage & Travel Tips
- 2 – 25 °C; refrigerate > 30 °C climates.
- Avoid direct sunlight; cocoa‑butter base melts at 35 °C.
- Mesacol – Oral mesalamine 800 mg for pancolitis.
- Rifaximin – Antibiotic modulation in IBS‑D overlap.
- Pentasa Tablet – 500 mg slow‑release granules.
- Proctosedyl – Hydrocortisone + cinchocaine for flare rescue.




